SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is currently trending due to its volatile price action and heavy discussion surrounding its potential as a high-growth AI-powered advertising leader versus concerns about software sector weakness. The community is actively debating whether recent pullbacks represent an accumulation opportunity for a durable cash-flow machine or if market-wide rotation and analyst sentiment shifts signal further downside risk.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is facing intense volatility as traders pivot between solar-specific sector concerns and speculative capital rotations into upcoming high-profile market debuts. The community remains deeply divided, with some investors aggressively averaging down on the belief that future data center energy and grid storage integration will drive a long-term turnaround, while others express frustration over severe technical breakdowns and the impact of broader market algorithmic trading.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is at the center of heated market debate following the successful 13th Starship test flight, which saw the deployment of next-generation Starlink satellites despite subsequent after-hours volatility. The community remains deeply divided, with bulls pointing to the company's long-term engineering potential and institutional accumulation, while bears emphasize valuation concerns and significant selling pressure from upcoming insider lock-up expirations.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is facing high volatility as investors navigate a combination of sector-wide defense rotation, index-related selling pressure, and ongoing speculation surrounding its production capacity and contract execution. While community sentiment remains split between long-term confidence in its unique battery technology and frustration over the stock's recent sharp decline, many are watching closely for a potential rebound fueled by domestic defense spending and upcoming earnings results.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is under scrutiny as investors weigh the potential for a breakup with Waymo against the companys push into international delivery through the pending Delivery Hero acquisition. The community remains divided, with many expressing frustration over the stock's stagnant price action while others double down on the long-term potential of its platform-wide scale and autonomous strategy.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently a focal point for investors as the community debates whether the recent pullback creates a buying opportunity ahead of upcoming earnings or reflects structural concerns about regulatory hurdles and supply chain dependencies. While short sellers highlight risks like permit rejections and raw material sourcing, bulls are aggressively buying the dip, banking on the company's critical role in meeting the surging power demands of AI data centers.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently driven by heightened market speculation regarding potential buyout interest and upcoming clinical data presentations in May. The community remains deeply divided, with optimistic investors highlighting insider confidence and the novel mechanism of soquelitinib, while vocal skeptics point to the company's long-term reliance on rehashed phase 1 results and persistent cash burn.

Lemonade, Inc. is a holding company, which engages in the provision of insurance services. The firm's products include renters and homeowners insurance, and pet insurance. It offers insurance coverage under the homeowners multi-peril, inland marine, and general liability lines of business. The company was founded by Daniel Asher Schreiber and Shai Wininger on June 17, 2015 and is headquartered in New York, NY.

Lemonade Inc

Lemonade is experiencing significant volatility as investors weigh strong quarterly growth against broader concerns about the company's timeline to profitability. Community sentiment is deeply divided, with many long-term bulls highlighting the company's AI-driven underwriting and improving loss ratios as signs of a long-term disruptor, while bears remain focused on the stock's continued lack of consistent net income and recent downward price pressure.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

ProShares Ultra Bloomberg Crude Oil is trending as investors react to volatile geopolitical headlines surrounding U.S.-Iran negotiations, military escalations, and their impact on global supply flows. The community remains deeply divided, actively debating whether the persistent conflict will drive oil prices higher or if a potential diplomatic resolution and rising alternative energy production will trigger a supply-driven price crash.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing intense selling pressure as investors grapple with concerns over the company's aggressive debt-funded AI infrastructure expansion and potential reliance on OpenAI. While a major government contract has served as an immediate catalyst, community sentiment remains deeply divided between those viewing the current valuation as a generational buying opportunity and others fearing a continued downward trend driven by institutional skepticism.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alnylam Pharmaceuticals (ALNY) Reports Next Week: Wall Street Expects Earnings Growth

Alnylam (ALNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the second quarter ending June 30, 2026 on Thursday, July 30, 2026, before the U.S. financial markets open. Management will provide an update on the Company...

Alnylam Highlights Progress with Neuroscience Programs at AAIC 2026, Showcasing Potential of RNAi in Neurological Disease

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today shared advances across its growing neuroscience portfolio at the Alzheimers Association International Conference (AAIC) 2026. This scientific progress underscores the potential of RNAi therapeutics to address...

BBIO Stock Surges 16% As AstraZeneca-Ionis Heart Drug Trial Misses Goal — BofA Calls Failure ‘A Big Surprise’

Equity

AstraZeneca and Ionis announced on Thursday  that their late-stage CARDIO-TTRansform trial for eplontersen (Wainua) failed to meet its main goal.


Nasdaq 100 Movers: PEP, ALNY

In early trading on Thursday, shares of Alnylam Pharmaceuticals topped the list of the day's best performing components of the Nasdaq 100 index, trading up 15.4%. Year to date, Alnylam Pharmaceuticals has lost about 6.1% of its value.

And the worst performing Nasdaq 100 compon...

AstraZeneca's Stock Drops on Wainua's Setback in ATTR-CM Study

AZN shares tumble after Wainua missed the primary endpoint in a late-stage ATTR-CM study, raising questions about its expansion into a larger market.

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers

Virax Biolabs Group (NASDAQ:VRAX) stock increased by 134.0% to $7.44 during Thursday's pre-market session. The company's market cap stands at $2.5 million.
Alnylam Pharmaceuticals (NASDAQ:ALNY) stockread more...

Can Alnylam's Drug Pipeline Fuel Its Long-Term Revenue Growth?

ALNY's advancing pipeline and partnered programs can expand future revenue sources alongside its growing portfolio of approved therapies.

Regeneron's Applications for gMG Drug Accepted by FDA and EMA 

Regeneron's cemdisiran won FDA Priority Review and EMA filing acceptance for gMG, backed by phase III data and a potentially unique dosing schedule.

Here's How Much $100 Invested In Alnylam Pharmaceuticals 10 Years Ago Would Be Worth Today

Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 10 years by 3.79% on an annualized basis producing an average annual return of 17.65%. Currently, Alnylam Pharmaceuticals has a marketread more...

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

Bearish Sentiment

Track ALNY stock price, charts, news and real-time market activity on Stocktwits. Join the ALNY message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Alnylam Pharmaceuticals Inc stock.

ALNY Stock Price Today - Alnylam Pharmaceuticals Inc News, Charts, Retail Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$1.63	--	--	N/A
Q1 '26	$0.89	$1.51	68.72%	BEAT
Q4 '25	$1.16	$0.82	-29.06%	MISSED
Q3 '25	$0.56	$1.84	228.01%	BEAT
Q2 '25	-$0.54	-$0.51	6.20%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

ALNYAlnylam Pharmaceuticals Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest ALNY News